126 related articles for article (PubMed ID: 712479)
1. Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors.
Carpentieri U; Balch MT
J Pediatr; 1978 Nov; 93(5):775-8. PubMed ID: 712479
[TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
[TBL] [Abstract][Full Text] [Related]
3. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone.
Pui CH; Burghen GA; Bowman WP; Aur RJ
J Pediatr; 1981 Jul; 99(1):46-50. PubMed ID: 6454771
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic complications of the treatment of acute leukemia with L-asparaginase (apropos of 147 cases)].
Bauters F; Mouton J; Delmas-Marsalet Y; Goudemand M
Lille Med; 1973 Dec; 18(10):1207-14 passim. PubMed ID: 4212519
[No Abstract] [Full Text] [Related]
6. Study of beta-cell function and erythrocyte insulin receptors in a patient with diabetic ketoacidosis associated with L-asparaginase therapy.
Rovira A; Cordido F; Vecilla C; Bernácer M; Valverde I; Herrera Pombo JL
Acta Paediatr Scand; 1986 Jul; 75(4):670-1. PubMed ID: 3092563
[No Abstract] [Full Text] [Related]
7. Hyperglucagonemia in L-asparaginase induced diabetes mellitus.
Rao SP; Castells S
Am J Pediatr Hematol Oncol; 1986; 8(1):83-5. PubMed ID: 3521362
[No Abstract] [Full Text] [Related]
8. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
[No Abstract] [Full Text] [Related]
9. Hyperglycemia and acute parotitis related to L-asparaginase therapy.
Uysal K; Uguz A; Olgun N; Sarialioglu F; Büyükgebiz A
J Pediatr Endocrinol Metab; 1996; 9(6):627-9. PubMed ID: 9004180
[TBL] [Abstract][Full Text] [Related]
10. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase.
Dacou-Voutetakis C; Palis J; Haidas S; Zannos-Mariolea L; Georgiopoulou P; Matsaniotis N
Am J Pediatr Hematol Oncol; 1983; 5(2):139-46. PubMed ID: 6351658
[TBL] [Abstract][Full Text] [Related]
11. Relative hyperglucagonemia in L-asparaginase-and prednisone-induced glucose intolerance in management of acute lymphocytic leukemia.
Turner GR; Marks JF; Buchanan GR
Clin Pediatr (Phila); 1983 May; 22(5):363-7. PubMed ID: 6340906
[TBL] [Abstract][Full Text] [Related]
12. L-asparaginase related hyperglycemia.
Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
[TBL] [Abstract][Full Text] [Related]
13. [Further observations on the treatment of acute lymphocytic leukemia in children with L-asparaginase].
Curtoni E; Astaldi G; Severi F; Genova R; Colombo A; Astaldi AA; Burgio GR
Minerva Pediatr; 1970 Sep; 22(37):1829-33. PubMed ID: 5274176
[No Abstract] [Full Text] [Related]
14. Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
[No Abstract] [Full Text] [Related]
15. [Acute diabetes during l-asparaginase treatment of acute leukosis].
Mallarme J; Chimènes H
Diabete; 1969; 17(2):95-8. PubMed ID: 5275053
[No Abstract] [Full Text] [Related]
16. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
Zajaczkowski J; Pituch A; Legutko L; Pajak E
Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
[TBL] [Abstract][Full Text] [Related]
17. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy.
Weetman RM; Baehner RL
Cancer; 1974 Sep; 34(3):780-5. PubMed ID: 4527863
[No Abstract] [Full Text] [Related]
18. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
Liebman HA; Wada JK; Patch MJ; McGehee W
Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
[TBL] [Abstract][Full Text] [Related]
19. Diabetes in patients treated with asparaginase.
Gailani S; Nussbaum A; Onuma T; Freeman A
Clin Pharmacol Ther; 1971; 12(3):487-90. PubMed ID: 5284834
[No Abstract] [Full Text] [Related]
20. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
